5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Scaffolds for alternative delivery

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          SADEL project aims at developing the first generation of non-parenteral biotherapeutics tackling disease targets in digestive track by using innovative high-affinity protein scaffolds. SADEL consortium is assembled as a virtual biopharmaceutical company with SMEs, academics, clinicians and pharma industry with all cutting-edge skills: production (including GMP), analytics, formulation, preclinical and clinical development, up to licensing.

          Related collections

          Author and article information

          Journal
          Impact
          impact
          Science Impact, Ltd.
          2398-7073
          November 18 2016
          November 18 2016
          : 2016
          : 2
          : 86-88
          Article
          10.21820/23987073.2016.2.86
          © 2016

          This work is licensed under a Creative Commons Attribution 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

          Earth & Environmental sciences, Medicine, Computer science, Agriculture, Engineering

          Comments

          Comment on this article